| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.38 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.31 | 0.05 |